Clinuvel Pharmaceuticals Ltd
(FRA:UR9)
€
8.295
-0.05 (-0.6%)
Market Cap: 424.17 Mil
Enterprise Value: 311.00 Mil
PE Ratio: 19.67
PB Ratio: 3.39
GF Score: 92/100 Full Year 2022 Clinuvel Pharmaceuticals Ltd Earnings Presentation Transcript
Aug 30, 2022 / 08:00AM GMT
Release Date Price:
€12.11
(+2.19%)
Verity Wai;Smith
Monsoon Communications - Analyst
Presentation
Aug 30, 2022 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Malcolm Bull
Clinuvel Pharmaceuticals Limited - Head of Australian Operations&IR
* Darren Keamy
Clinuvel Pharmaceuticals Limited - CFO, Company Secretary
* Philippe Wolgen
Clinuvel Pharmaceuticals Limited - CEO
=====================
Conference Call Participants
=====================
* Verity Wai-Smith
Monsoon Communications - Analyst
=====================
- -
Malcolm Bull
Clinuvel Pharmaceuticals Limited - Head of Australian Operations&IR
Good evening, everyone. I'm Verity from Monsoon Communications. Thank you for joining us for Clinuvel's annual results briefing for the 2022 financial year. I'll now hand over to Malcolm Bull to begin the presentation.
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot